CROSSROADS STRATEGIES, LLC

Lobbying for MADRIGAL PHARMACEUTICALS, INC. · biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

Issues related to drug pricing; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

Medicare/Medicaid

Issues related to CMMI Drug Pricing Demonstration Programs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.